Bookedited by Robert A. Britton, Baylor College of Medicine, Molecular Virology and Microbiology,
... Show More Houston, Texas, Patrice D. Cani, Université catholique de Louvain, Louvain Drug Research Institute, WELBIO-Walloon Excellence in Life Sciences, Brussels, Belgium.
Summary: Examining the enormous potential of microbiome manipulation to improve health.
Contents:
A. TRADITIONAL PROBIOTIC APPROACHES. Chapter 1. Biochemical features of beneficial microbes : foundations for therapeutic microbiology / Melinda A. Engevik, James Versalovic
Chapter 2. The genomic basis of lactobacilli as health-promoting organisms / Elisa Salvetti, Paul W. O'Toole
Chapter 3. Bifidobacteria and their health-promoting effects / Claudio Hidalgo-Cantabrana, Susana Delgado, Lorena Ruiz, Patricia Ruas-Madiedo, Borja Sánchez, Abelardo Margolles
B. NEXT-GENERATION BACTERIOTHERAPY: OPPORTUNITIES IN CHRONIC DISEASES. Chapter 4. Microbial interactions and interventions in colorectal cancer / Terence van Raay, Emma Allen-Vercoe
Chapter 5. Microbial impact on host metabolism: opportunities for novel treatments of nutritional disorders? / Hubert Plovier, Patrice D. Cani
Chapter 6. Therapeutic opportunities in the vaginal microbiome / Gregor Reid
Chapter 7. Lung microbiota and its impact on the mucosal immune phenotype / Benjamin G. Wu, Leopoldo N. Segal
Chapter 8. Microbiota, liver diseases, and alcohol / Anne-Marie Cassard, Philippe Gérard, Gabriel Perlemuter
Chapter 9. The potential of probiotics as a therapy for osteoporosis / Fraser L. Collins, Naiomy D. Rios-Arce, Jonathan D. Schepper, Narayanan Parameswaran, Laura R. McCabe
Chapter 10. Ecological therapeutic opportunities for oral diseases / Anilei Hoare, Philip D. Marsh, Patricia I. Diaz
C. CONTROL OF INFECTIOUS DISEASE BY MICROBES. Chapter 11. Control of Clostridium difficile infection by defined microbial communities / James Collins, Jennifer M. Auchtung
Chapter 12. Fecal microbiota transplantation : therapeutic potential for a multitude of diseases beyond Clostridium difficile / Guido J. Bakker, Max Nieuwdorp
Chapter 13. Enterococci and their interactions with the intestinal microbiome / Krista Dubin, Eric G. Palmer
D. NEXT-GENERATION MICROBIAL THERAPEUTICS: TOOLS AND REGULATION. Chapter 14. Engineering diagnostic and therapeutic gut bacteria / Brian P. Landry, Jeffrey J. Tabor
Chapter 15. Use of traditional and genetically modified probiotics in human health : what does the future hold? / Luis G. Bermúdez-Humarán, Philippe Langella
Chapter 16. Genetic tools for the enhancement of probiotic properties / Laura Ortiz-Velez, Robert Britton
Chapter 17. Genome editing of food-grade lactobacilli to develop therapeutic probiotics / Jan-Peter van Pijkeren, Rodolphe Barrangou
Chapter 18. United States regulatory considerations for development of live biotherapeutic products as drugs / Sheila M. Dreher-Lesnick, Scott Stibitz, Paul E. Carlson, Jr.
E. INDIRECT STRATEGIES TO TARGET MICROBIOME FUNCTION FOR HEALTH. Chapter 19. Bacteriophage clinical use as antibacterial “drugs” : utility and precedent / Stephen T. Abedon
Chapter 20. Modulation of the gastrointestinal microbiome with nondigestable fermentable carbohydrates to improve human health / Edward C. Deehan, Rebbeca M. Duar, Anissa M. Armet, Maria Elisa Perez-Muñoz, Mingliang Jin, Jens Walter.